-
My Account
In App
My Account
| Particulars | This Scheme | Category |
|---|---|---|
| No. of Stocks | 20 | 77.02 |
| Top 5 Stock Weight | 52.06% | 36.98% |
| Top 10 Stock Weight | 77.32% | 54.12% |
| Top 3 Sector Weight | 99.98% | 34.2% |
| Particulars | This Scheme | Category |
|---|---|---|
| Average mcap (Cr) | 34718.99 | 112270.48 |
| Holdings in large cap stocks | 43.55% | 50.55% |
| Holdings in mid cap stocks | 25.3% | 15.75% |
| Holdings in small cap stocks | 0% | 8.59% |
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| # Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 25.2 | 18.15% | 0.00% | 18.51% (Jul 2025) | 0% (Oct 2024) | 14.89 k | 557.00 |
| # Divis Laboratories Ltd. | Pharmaceuticals | 12.1 | 8.72% | 0.00% | 8.73% (Jun 2025) | 0% (Oct 2024) | 1.79 k | 67.00 |
| # Max Healthcare Institute Ltd. | Hospital | 12.1 | 8.69% | 0.00% | 9.58% (Jun 2025) | 0% (Oct 2024) | 10.50 k | 392.00 |
| # Cipla Ltd. | Pharmaceuticals | 11.9 | 8.60% | 0.00% | 9.32% (Aug 2025) | 0% (Oct 2024) | 7.95 k | 298.00 |
| # Apollo Hospitals Enterprises Ltd. | Hospital | 11 | 7.90% | 0.00% | 8.02% (Aug 2025) | 0% (Oct 2024) | 1.43 k | 53.00 |
| # Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 10.3 | 7.43% | 0.00% | 8% (Aug 2025) | 0% (Oct 2024) | 8.61 k | 322.00 |
| # Fortis Healthcare Ltd. | Hospital | 7.5 | 5.43% | 0.00% | 5.31% (Sep 2025) | 0% (Oct 2024) | 7.36 k | 276.00 |
| # Lupin Ltd. | Pharmaceuticals | 6.7 | 4.84% | 0.00% | 4.86% (Sep 2025) | 0% (Oct 2024) | 3.42 k | 128.00 |
| # Torrent Pharmaceuticals Ltd. | Pharmaceuticals | 5.3 | 3.79% | 0.00% | 3.96% (Sep 2025) | 0% (Oct 2024) | 1.48 k | 55.00 |
| # Laurus Labs Ltd. | Pharmaceuticals | 5.2 | 3.77% | 0.00% | 3.5% (Aug 2025) | 0% (Oct 2024) | 5.49 k | 205.00 |
| Stock Invested in |
Sector |
Sector Total |
Value(Mn) |
% of Total Holdings |
1M Change |
1Y Highest Holding |
1Y Lowest Holding |
Quantity |
1M Change in Qty |
M-Cap |
GroupName |
|---|---|---|---|---|---|---|---|---|---|---|---|
| # Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 76.7 | 25.2 | 18.15% | 0.00% | 18.51% (Jul 2025) | 0% (Oct 2024) | 14.89 k | 557.00 | Large Cap | 43.55 |
| # Divis Laboratories Ltd. | Pharmaceuticals | 76.7 | 12.1 | 8.72% | 0.00% | 8.73% (Jun 2025) | 0% (Oct 2024) | 1.79 k | 67.00 | Large Cap | 43.55 |
| # Max Healthcare Institute Ltd. | Hospital | 22.02 | 12.1 | 8.69% | 0.00% | 9.58% (Jun 2025) | 0% (Oct 2024) | 10.50 k | 392.00 | Other | 31.13 |
| # Cipla Ltd. | Pharmaceuticals | 76.7 | 11.9 | 8.60% | 0.00% | 9.32% (Aug 2025) | 0% (Oct 2024) | 7.95 k | 298.00 | Large Cap | 43.55 |
| # Apollo Hospitals Enterprises Ltd. | Hospital | 22.02 | 11 | 7.90% | 0.00% | 8.02% (Aug 2025) | 0% (Oct 2024) | 1.43 k | 53.00 | Mid Cap | 25.3 |
| # Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 76.7 | 10.3 | 7.43% | 0.00% | 8% (Aug 2025) | 0% (Oct 2024) | 8.61 k | 322.00 | Other | 31.13 |
| # Fortis Healthcare Ltd. | Hospital | 22.02 | 7.5 | 5.43% | 0.00% | 5.31% (Sep 2025) | 0% (Oct 2024) | 7.36 k | 276.00 | Other | 31.13 |
| # Lupin Ltd. | Pharmaceuticals | 76.7 | 6.7 | 4.84% | 0.00% | 4.86% (Sep 2025) | 0% (Oct 2024) | 3.42 k | 128.00 | Large Cap | 43.55 |
| # Torrent Pharmaceuticals Ltd. | Pharmaceuticals | 76.7 | 5.3 | 3.79% | 0.00% | 3.96% (Sep 2025) | 0% (Oct 2024) | 1.48 k | 55.00 | Mid Cap | 25.3 |
| # Laurus Labs Ltd. | Pharmaceuticals | 76.7 | 5.2 | 3.77% | 0.00% | 3.5% (Aug 2025) | 0% (Oct 2024) | 5.49 k | 205.00 | Other | 31.13 |
| # Aurobindo Pharma Ltd. | Pharmaceuticals | 76.7 | 4.5 | 3.24% | 0.00% | 3.21% (Jun 2025) | 0% (Oct 2024) | 3.95 k | 148.00 | Large Cap | 43.55 |
| # Alkem Laboratories Ltd. | Pharmaceuticals | 76.7 | 4.4 | 3.16% | 0.00% | 3.21% (Sep 2025) | 0% (Oct 2024) | 795.00 | 29.00 | Mid Cap | 25.3 |
| # Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | 76.7 | 4 | 2.90% | 0.00% | 3.23% (Jul 2025) | 0% (Oct 2024) | 2.13 k | 80.00 | Mid Cap | 25.3 |
| # Mankind Pharma Ltd. | Pharmaceuticals | 76.7 | 3.8 | 2.75% | 0.00% | 2.92% (Jul 2025) | 0% (Oct 2024) | 1.60 k | 60.00 | Other | 31.13 |
| # Zydus Lifesciences Ltd. | Pharmaceuticals | 76.7 | 3.4 | 2.48% | 0.00% | 2.58% (Sep 2025) | 0% (Oct 2024) | 3.53 k | 132.00 | Mid Cap | 25.3 |
| # Biocon Ltd. | Pharmaceuticals | 76.7 | 3.2 | 2.28% | 0.00% | 2.36% (Jul 2025) | 0% (Oct 2024) | 8.48 k | 318.00 | Mid Cap | 25.3 |
| # Ipca Laboratories Ltd. | Pharmaceuticals | 76.7 | 2.5 | 1.80% | 0.00% | 2.06% (Jul 2025) | 0% (Oct 2024) | 1.96 k | 73.00 | Other | 31.13 |
| # Abbott India Ltd. | Pharmaceuticals | 76.7 | 2.1 | 1.53% | 0.00% | 1.89% (Jun 2025) | 0% (Oct 2024) | 73.00 | 2.00 | Mid Cap | 25.3 |
| # Piramal Pharma Ltd. | Pharmaceuticals | 76.7 | 1.7 | 1.26% | 0.00% | 1.24% (Sep 2025) | 0% (Oct 2024) | 8.73 k | 327.00 | Other | 31.13 |
| # Syngene International Ltd. | Healthcare research, analytics & technology | 1.26 | 1.7 | 1.26% | 0.00% | 1.36% (Jul 2025) | 0% (Oct 2024) | 2.68 k | 100.00 | Mid Cap | 25.3 |
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| No new entrants in the portfolio in the last month. | ||||||||
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| No complete exits in the portfolio in the last month. | ||||||||
| Stock | Oct 2025 | Sep 2025 | Aug 2025 | Jul 2025 | Jun 2025 | May 2025 | Apr 2025 | Mar 2025 | Feb 2025 | Jan 2025 | Dec 2024 | Nov 2024 | Oct 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 18.15% | 17.67% | 17.93% | 18.51% | 18.25% | - | - | - | - | - | - | - | - |
| Max Healthcare Institute Ltd. | 8.69% | 8.71% | 8.95% | 9.31% | 9.58% | - | - | - | - | - | - | - | - |
| Cipla Ltd. | 8.60% | 8.89% | 9.32% | 8.79% | 8.56% | - | - | - | - | - | - | - | - |
| Divis Laboratories Ltd. | 8.72% | 7.60% | 8.12% | 8.42% | 8.73% | - | - | - | - | - | - | - | - |
| Dr. Reddys Laboratories Ltd. | 7.43% | 7.84% | 8.00% | 7.78% | 7.89% | - | - | - | - | - | - | - | - |
| Apollo Hospitals Enterprises Ltd. | 7.90% | 7.87% | 8.02% | 7.62% | 7.39% | - | - | - | - | - | - | - | - |
| Fortis Healthcare Ltd. | 5.43% | 5.31% | 4.95% | 4.49% | 4.18% | - | - | - | - | - | - | - | - |
| Lupin Ltd. | 4.84% | 4.86% | 4.78% | 4.69% | 4.73% | - | - | - | - | - | - | - | - |
| Torrent Pharmaceuticals Ltd. | 3.79% | 3.96% | 3.88% | 3.93% | 3.60% | - | - | - | - | - | - | - | - |
| Laurus Labs Ltd. | 3.77% | 3.44% | 3.50% | 3.44% | 2.87% | - | - | - | - | - | - | - | - |
| Aurobindo Pharma Ltd. | 3.24% | 3.19% | 3.00% | 3.21% | 3.21% | - | - | - | - | - | - | - | - |
| Glenmark Pharmaceuticals Ltd. | 2.90% | 3.09% | 3.02% | 3.23% | 2.67% | - | - | - | - | - | - | - | - |
| Alkem Laboratories Ltd. | 3.16% | 3.21% | 2.98% | 2.72% | 2.69% | - | - | - | - | - | - | - | - |
| Mankind Pharma Ltd. | 2.75% | 2.90% | 2.91% | 2.92% | 2.65% | - | - | - | - | - | - | - | - |
| Zydus Lifesciences Ltd. | 2.48% | 2.58% | 2.55% | 2.44% | 2.50% | - | - | - | - | - | - | - | - |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 0.83% |
| Net Receivables | Net Receivables | -0.81% |
Why Chase Market Highs with Risk When Fixed Returns are Right Here? 10.55% MEGHALAYA ENERGY CORPORATION LIMITED 2033 ✔️ Coupon: 10.55% ✔️ Rating: Acuite A-(CE) Stable, BRICKWORK A-(CE) Stable ✔️ Tenor: 7y 4m (Maturity: 03/Apr/2033)** Secured Bond | PSU Bond | High Return Bond | Listed Invest in a PSU-backed secured bond delivering a high fixed return, the smarter way to stay stable and grow money stronger. ???? Explore on The Fixed Income: https://www.thefixedincome.com/product/dVJPb1pnPT0=/1055-meghalaya-energy-corporation-limited-2033?utm_source=Moneycontrol&utm_medium=Forum&utm_campaign=Product_list View more
Posted by : The Fixed Income
Repost this message
Why Chase Market Highs with Risk When Fixed Returns are Right Here? 10.55% MEGHALAYA ENERGY CORPORATION LIMITED 2033 ✔️ Coupon: 10.55% ✔️ Rating: Acuite A-(CE) Stable, BRICKWORK A-(CE) Stable ✔️ Tenor: 7y 4m (Maturity: 03/Apr/2033)** Secured Bond | PSU Bond | High Return Bond | Listed Invest in a PSU-backed secured bond delivering a high fixed return, the smarter way to stay stable and grow money stronger. ???? Explore on The Fixed Income: https://www.thefixedincome.com/product/dVJPb1pnPT0=/1055-meghalaya-energy-corporation-limited-2033?utm_source=Moneycontrol&utm_medium=Forum&utm_campaign=Product_list
need your suggestion for sbi psu fund direct growth stay or switch View more
Posted by : shravanashok
Dividend last declared by SBI Long Term Equity Fund - regular Plan -IDCW was in the year 2022. Is there any specific reason given by fund managers for non declaration of dividend. Please let me know. View more
Posted by : ravisistla
Hello sir, I have been invested in these funds since 2017. Last SIP was in 2021. As their NAV have grown so I was thinking of switching to other funds with lower NAV. View more
Posted by : sunny85deol
